«Publication Policies and Procedures for the Journals of the American Diabetes Association Last updated 30 October 2015 The American Diabetes Care ...»
Publication of a notice of scientific or academic misconduct, such as redundant or duplicate publication or plagiarism, if appropriate and unequivocally documented. Such publication will not require approval of authors, and will be reported to the author(s)’ institution and, if appropriate, funding agency.
Formal withdrawal or retraction of the paper from the scientific literature, published in the journal, informing readers and the indexing authorities (National Library of Medicine, etc) if there is a formal finding of misconduct by ADA or the author(s)’ institution. Such publication will not require approval of authors; will be reported to, if appropriate, the author(s)’ institution and/or funding agency; and will be readily visible and identifiable in the journal.
Any withdrawal or retraction published in the journal will meet the requirements established by ICMJE.
Reporting Concerns Related to Scientific Misconduct Any individual may report concerns related to possible misconduct involving ADA scientific programs or publications by e-mail to email@example.com. Correspondents should provide as much information as possible to clearly describe the potential instances of misconduct, as well as the specific citation information or grant submission number, if available, for the work in question. These concerns will be reviewed by the Association’s Panel on Ethical Scientific Programs (ESP). The ESP will only review concerns related to possible research and scientific misconduct, and will not review challenges to any decision regarding a submitted manuscript, abstract, or grant application.
Peer Review ADA Journals employ a single-blinded review process: authors are blinded to the identities of the editors and reviewers responsible for the independent peer review of their manuscripts, but not vice versa.
Original Articles, Brief Reports, Perspectives and Review Articles, and Supplemental Articles are invited for peer review by the editors.
The Editor-in-Chief assesses each submission to the journal to determine whether the content and subject of the manuscript is appropriate for the journal. Due to an increasing number of submissions and limited editorial space, only those manuscripts that meet a priority score, as determined by the Editor, above the 50th percentile will be reviewed. Each manuscript that meets the priority score above the 50th percentile is assigned to an Associate Editor who is versed in the subject area of the manuscript. The Associate Editor will invite expert researchers to peer review the manuscript. Based on the reviews of three peer reviewers, the Associate Editor will recommend a decision to accept the manuscript for publication, reject the manuscript, or suggest that the authors revise and resubmit the manuscript. The Editor-in-Chief is responsible for determining and conveying the final decision on all manuscripts. The Editor-in-Chief may consult with other Editorial Board members if there is significant divergence of opinion among the Associate Editors and/or the peer reviewers on how a manuscript should be decided. All correspondence related to the peer review of each manuscript is confidential.
The peer reviewers for ADA Journals are experts chosen by the Associate Editors to provide written objective assessments of the strengths and weaknesses of original research manuscripts, with the aim of improving the reporting of research and identifying the most appropriate, timely, and highest-quality research for the journal. Researchers are invited to review manuscripts submitted to the journals on the bases of their objectivity, scientific knowledge, and level of expertise. Reviewers for ADA journals are required to disclose whether they have any competing interest related to the subject of the article or the authors (e.g., those working for a company whose product was tested, its competitors, or the same institution as the authors, etc.).
ADA journals seek reviews that are professional, honest, courteous, prompt, and constructive. Editors may edit reviews before sending them to authors, or simply not send them if they feel they are not constructive or appropriate. The desired major elements of a high-quality review, as outlined by the
WAME, are as follows:
The reviewer should have identified and commented on major strengths and weaknesses of study design and methodology, and should identify the major strengths and weaknesses of the manuscript as a written communication, independent of the design, methodology, results, and interpretation of the study.
The reviewer should comment accurately and constructively upon the quality of, and the author's interpretation of, the data, including acknowledgment of its limitations.
The reviewer should comment on any ethical concerns raised by the study, or any evidence of potential scientific misconduct.
The reviewer should provide the author with useful suggestions for improvement of the manuscript when appropriate.
The reviewer's comments to the author should be cordial and constructively critical.
The review should provide the editor the proper context and perspective to make a decision on acceptance (and/or revision) of the manuscript.
Reviewers are provided with a one-page set of reviewer guidelines each time they accept an invitation to review a manuscript. Reviewers are also encouraged to refer to "Enhancing Peer Review of Scientific Manuscripts" [Arch Intern Med 157:380-381 (1997)] for further guidance on drafting a high-quality review.
After each review is submitted, the Associate Editors rate the quality and the timeliness of the review, and this information is recorded in the peer-review database. Ratings of review quality and timeliness are periodically assessed to assure optimal journal performance and, as such, contribute to decisions regarding ongoing review requests. Individual performance data are kept confidential.
ADA recognizes that the submitted manuscript is a privileged communication, and reviewers are required to treat each manuscript as confidential. Reviewers are not allowed to retain, copy, or share manuscripts. Reviewers and editors are not permitted to make any personal or professional use of the data, arguments, or interpretations (other than those directly involved in its peer review) prior to publication unless they have the authors' specific permission or are writing an editorial or commentary to accompany the article.
If reviewers suspect misconduct, they are asked to notify the editor in confidence; reviewers should not share their concerns with other parties. In cases involving reviewer- or editor-identified suspected misconduct (e.g., possible duplicate submission, plagiarism, etc.) in a submitted manuscript to ADA Journals and a submitted manuscript to another publication, ADA Journalsmay provide a review copy of a submitted paper to an editor of another journal, with the understanding that the review paper could not be shared with any outside party, in order to efficiently and fairly appraise the validity and legitimacy of such suspicions. This step would only be taken if the author(s) did not satisfactorily respond to an initial letter of inquiry from the editors.
Information about each journal’s acceptance rates, publication intervals, and other performance data can be found in the “About the Journal” page of the online journal. Updated statistics are posted in July/August of each year.
Editorial Decisions In accordance with the recommendations of WAME, decisions about manuscripts submitted to ADA journals are based on the manuscripts’ importance, originality, clarity, and relevance to the journal's scope and content. Editors are asked to give equal consideration to studies with negative results despite adequate power, or those challenging previously published work.
If an author chooses to appeal a decision, the author should contact the Editorial Office at firstname.lastname@example.org. The corresponding author should clearly explain the reason for appealing the decision. Depending on the reason, the Editorial Office will forward the appeal to either the Editorin-Chief (if, for instance, the author disagrees with the recommendations of the reviewer or Associate Editors) or ADA’s Scientific & Medical Department (if, for example, the author alleges a form of editorial conflict-of-interest or misconduct).
Manuscripts authored or co-authored by a member of the current Editorial Team will be decided by an independent “Ad Hoc Editor” (e.g., a previous editor not affiliated with the author’s editorial team). An Ad Hoc Editor will also be assigned manuscripts for which the Editor is required to recuse her/himself from the peer-review process because of a potential conflict of interest or personal or professional bias.
ADA Editorial Office staff will assist the Ad Hoc Editor with inviting and selecting reviewers. Members of the current Editorial Team are blinded to the peer-review of manuscripts overseen by the Ad Hoc Editor.
Prepublication of Accepted Articles To make research readily available to subscribers, Diabetes Care and Diabetes publish accepted articles online ahead of print 5-6 weeks after acceptance, after articles have been copyedited, proofread, and typeset.
Online Ahead of Print articles are citable by their unique DOI (digital object identifier). DOIs for ADA Journals articles begin with 10.2337, followed by the article number assigned when the manuscript was submitted online via the manuscript submission system (e.g., 10.2337/dc11-1234).
Copyright, Reuse, and Public Access Copyright. The American Diabetes Association holds copyright on all content published in ADA Journals, unless otherwise noted. Readers may use the content as long as the work is properly cited and linked to the original source, the use is educational and not for profit, and the work is not altered. Diabetes articles may not be included without ADA permission in educational materials that are sold to students or used in courses for which tuition or other fees are charged.
Reuse. Authors are permitted to reuse portions of their ADA-copyrighted work, including tables and figures, in their own work, and to reuse portions or all of their ADA-copyrighted work for educational purposes, without submitting a request to ADA, provided that the proper citation and copyright information is given.
To submit a permission-to-reuse request to ADA, go to the online version of the article and click on “Get Permissions” to the right of the article.
Post-prints and public access. Authors are permitted to submit the final, accepted version of their manuscript to their funding body or institution for inclusion in their funding body or institution's database, archive, or repository, or to post the final, accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance, provided that the following
two conditions are observed:
First, post-prints must include the following statement of provenance and, once the final version has
been published in the journal, a link to the final published version of the paper on the journal's website:
“This is an author-created, uncopyedited electronic version of an article accepted for publication in [insert ADA Journal title]. The American Diabetes Care Association (ADA), publisher of [insert ADA Journal title], is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of [insert ADA Journal title] in print and online at [insert journal URL: http://care.diabetesjournals.org, http://diabetes.diabetesjournals.org, http://clinical.diabetesjournals.org, or http://spectrum.diabetesjournals.org].” Second, the version of the manuscript deposited or posted must be identical to the final accepted version, with the exception of the addition of the above statement and any changes necessary to correct errors. Authors may make changes to the posted version to correct mistakes or may issue an erratum at any time. However, the final published version of the manuscript may not be deposited, posted, or later substituted for the post-print.
As a courtesy to authors, the final print versions of articles funded by NIH will be deposited in PubMed Central (PMC) at no additional cost. In compliance with NIH’s policy, these articles will appear on PMC 12 months after print publication in Diabetes Care, Diabetes, Clinical Diabetes, or Diabetes Spectrum. All articles, regardless of funding body, are delivered to PubMed for inclusion in the PubMed index.
Full-text HTML versions of all articles are freely accessible on the ADA Journal sites 6 months after the print publication date, and PDF content becomes freely accessible 12 months after the print publication date.
Errata, Retractions, and Addenda Requests for submitting errata, retractions, or other updates should first be sent to the Association Editorial Office. Depending on the nature of the request, the Editorial Office will consult with the Editors or the Panel on Ethical Scientific Publications on how to proceed with the request.
Errata. Errata refer to errors introduced to the article by the author(s) or the publisher. ADA Journals will publish errata notices to communicate necessary corrections to such errors.
Errata will be published in the print and online versions of the journal. Errata are listed in the table of contents, are linked online to the articles to which they pertain, and are indexed in public databases such as PubMed. Errata should clearly cite and describe the reported error(s), including at what stage the error(s) was introduced; should clearly communicate the necessary correction(s) to the error(s); and address whether the errors originated with ADA staff or with the author.